Johnson & Johnson, a leading global healthcare company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1886, the company has established itself as a pioneer in the pharmaceutical, medical devices, and consumer health sectors. With a diverse portfolio that includes renowned products such as Band-Aid® adhesive bandages, Tylenol® pain relievers, and innovative surgical instruments, Johnson & Johnson is committed to improving health outcomes worldwide. The company is recognised for its dedication to quality and safety, which has solidified its position as a trusted name in healthcare. Notable achievements include its extensive research and development efforts, which have led to groundbreaking medical advancements. Johnson & Johnson continues to be a formidable player in the healthcare industry, driven by a mission to enhance the well-being of people globally.
How does Johnson & Johnson's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Johnson & Johnson's score of 28 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, Johnson & Johnson has not reported specific carbon emissions figures. However, the company has set ambitious climate commitments, aiming for net zero emissions across its entire value chain by 2045. This long-term goal encompasses all scopes of emissions, reflecting a comprehensive approach to climate action. Johnson & Johnson's commitment to sustainability is part of its broader environmental strategy, which includes various initiatives to reduce its carbon footprint. While specific reduction targets or achievements in terms of absolute emissions have not been disclosed, the company's focus on reaching net zero demonstrates a proactive stance in addressing climate change. The absence of detailed emissions data suggests that Johnson & Johnson is in the process of enhancing its reporting mechanisms or may be aligning its strategies with industry standards. As the company progresses towards its 2045 target, stakeholders can expect updates on its emissions performance and reduction initiatives in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Johnson & Johnson has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

